NASDAQ:CHSCL

CHS Competitors

$28.81
-0.05 (-0.17 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$28.70
Now: $28.81
$28.97
50-Day Range
$28.14
MA: $28.78
$29.09
52-Week Range
$24.88
Now: $28.81
$29.58
Volume14,125 shs
Average Volume27,058 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.07%
BetaN/A

Competitors

CHS (NASDAQ:CHSCL) Vs. RLX, COUR, HIMS, APPH, YQ, and FHS

Should you be buying CHSCL stock or one of its competitors? Companies in the sector of "consumer defensive" are considered alternatives and competitors to CHS, including RLX Technology (RLX), Coursera (COUR), Hims & Hers Health (HIMS), AppHarvest (APPH), 17 Education & Technology Group (YQ), and First High-School Education Group (FHS).

RLX Technology (NYSE:RLX) and CHS (NASDAQ:CHSCL) are both consumer defensive companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Profitability

This table compares RLX Technology and CHS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
RLX TechnologyN/AN/AN/A
CHSN/AN/AN/A

Earnings & Valuation

This table compares RLX Technology and CHS's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RLX TechnologyN/AN/AN/AN/AN/A
CHSN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings for RLX Technology and CHS, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
RLX Technology00303.00
CHS0000N/A

RLX Technology currently has a consensus price target of $23.3333, suggesting a potential upside of 156.98%. Given RLX Technology's higher probable upside, equities analysts plainly believe RLX Technology is more favorable than CHS.

Summary

RLX Technology beats CHS on 2 of the 2 factors compared between the two stocks.

Coursera (NASDAQ:COUR) and CHS (NASDAQ:CHSCL) are both consumer defensive companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Analyst Ratings

This is a breakdown of current ratings for Coursera and CHS, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Coursera00203.00
CHS0000N/A

Coursera currently has a consensus price target of $40.00, suggesting a potential downside of 2.44%. Given Coursera's higher probable upside, equities analysts plainly believe Coursera is more favorable than CHS.

Profitability

This table compares Coursera and CHS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CourseraN/AN/AN/A
CHSN/AN/AN/A

Earnings & Valuation

This table compares Coursera and CHS's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CourseraN/AN/AN/AN/AN/A
CHSN/AN/AN/AN/AN/A

Summary

Coursera beats CHS on 2 of the 2 factors compared between the two stocks.

CHS (NASDAQ:CHSCL) and Hims & Hers Health (NYSE:HIMS) are both consumer defensive companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Earnings and Valuation

This table compares CHS and Hims & Hers Health's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CHSN/AN/AN/AN/AN/A
Hims & Hers HealthN/AN/AN/AN/AN/A

Profitability

This table compares CHS and Hims & Hers Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CHSN/AN/AN/A
Hims & Hers HealthN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for CHS and Hims & Hers Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CHS0000N/A
Hims & Hers Health02202.50

Hims & Hers Health has a consensus price target of $19.00, suggesting a potential upside of 92.11%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than CHS.

Summary

Hims & Hers Health beats CHS on 2 of the 2 factors compared between the two stocks.

CHS (NASDAQ:CHSCL) and AppHarvest (NASDAQ:APPH) are both consumer defensive companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Earnings & Valuation

This table compares CHS and AppHarvest's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CHSN/AN/AN/AN/AN/A
AppHarvestN/AN/AN/AN/AN/A

Profitability

This table compares CHS and AppHarvest's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CHSN/AN/AN/A
AppHarvestN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and price targets for CHS and AppHarvest, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CHS0000N/A
AppHarvest00103.00

AppHarvest has a consensus target price of $42.00, suggesting a potential upside of 233.07%. Given AppHarvest's higher possible upside, analysts clearly believe AppHarvest is more favorable than CHS.

Summary

AppHarvest beats CHS on 2 of the 2 factors compared between the two stocks.

CHS (NASDAQ:CHSCL) and 17 Education & Technology Group (NYSE:YQ) are both consumer defensive companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Earnings & Valuation

This table compares CHS and 17 Education & Technology Group's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CHSN/AN/AN/AN/AN/A
17 Education & Technology GroupN/AN/AN/AN/AN/A

Profitability

This table compares CHS and 17 Education & Technology Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CHSN/AN/AN/A
17 Education & Technology GroupN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and price targets for CHS and 17 Education & Technology Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CHS0000N/A
17 Education & Technology Group00203.00

17 Education & Technology Group has a consensus target price of $21.00, suggesting a potential upside of 237.08%. Given 17 Education & Technology Group's higher possible upside, analysts clearly believe 17 Education & Technology Group is more favorable than CHS.

Summary

17 Education & Technology Group beats CHS on 2 of the 2 factors compared between the two stocks.

CHS (NASDAQ:CHSCL) and First High-School Education Group (NYSE:FHS) are both consumer defensive companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Analyst Ratings

This is a summary of current ratings and price targets for CHS and First High-School Education Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CHS0000N/A
First High-School Education Group0000N/A

Earnings & Valuation

This table compares CHS and First High-School Education Group's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CHSN/AN/AN/AN/AN/A
First High-School Education GroupN/AN/AN/AN/AN/A

Profitability

This table compares CHS and First High-School Education Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CHSN/AN/AN/A
First High-School Education GroupN/AN/AN/A


CHS Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
RLX
RLX Technology
1.7$9.08-2.2%$14.10 billionN/A0.00Gap Down
COUR
Coursera
1.6$41.00-2.6%$5.34 billionN/A0.00Analyst Report
Hims & Hers Health logo
HIMS
Hims & Hers Health
1.0$9.89-13.3%$1.89 billionN/A0.00
APPH
AppHarvest
1.2$12.61-10.9%$1.23 billionN/A0.00High Trading Volume
YQ
17 Education & Technology Group
1.2$6.23-4.5%$1.17 billionN/A0.00
FHS
First High-School Education Group
0.0$6.29-3.3%$182.07 millionN/A0.00Quiet Period Expiration
The Alkaline Water logo
WTER
The Alkaline Water
0.5$0.98-4.1%$85.74 millionN/A0.00
PLAG
Planet Green
0.0$2.40-17.1%$48.02 millionN/A0.00High Trading Volume
News Coverage
Gap Up
DOGZ
Dogness (International)
0.5$1.60-3.1%$32.48 millionN/A0.00
CHS logo
CHSCM
CHS
0.7$27.83-0.5%$0.00N/A0.00
CHS logo
CHSCO
CHS
0.5$28.63-0.4%$0.00N/A0.00
Demand Brands logo
DMAN
Demand Brands
0.4$0.01-0.0%$0.00N/A0.00
Good Hemp logo
GHMP
Good Hemp
0.0$1.07-1.6%$0.00N/A0.00Gap Down
TAP.A
Molson Coors Brewing
0.4$55.58-0.0%$0.00N/A0.00
QNTA
Quanta
0.0$0.06-16.9%$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
SHRG
Sharing Services Global
0.0$0.22-0.7%$0.00N/A0.00
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.